Castlight Health Inc. (NYSE:CSLT) shares fell to a low of $1.64 before closing at $1.90. Intraday shares traded counted 3.15 million, which was -158.42% lower than its 30-day average trading volume of 1.22M. CSLT’s previous close was $1.75 while the outstanding shares total 154.80M. The firm has a beta of 1.76. The stock’s Relative Strength Index (RSI) is 64.05, with weekly volatility at 9.78% and ATR at 0.14. The CSLT stock’s 52-week price range has touched low of $0.61 and a $2.36 high. The stock traded higher over the last trading session, gaining 8.57% on 04/30/21.
Investors have identified the Health Information Services company Castlight Health Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $276.39 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Castlight Health Inc. (CSLT) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 84.78 million total, with 34.31 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.07 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CSLT sounds very interesting.
Is the stock of CSLT attractive?
In related news, Director, Cohen Seth B. sold 17,119 shares of the company’s stock in a transaction that recorded on Feb 19. The sale was performed at an average price of 1.72, for a total value of 29,491. As the sale deal closes, the Chief Executive Officer, O’Meara Maeve now sold 59,615 shares of the company’s stock, valued at 112,887. Also, Chief Accounting Officer, Chan M.P. Eric sold 8,398 shares of the company’s stock in a deal that was recorded on Feb 17. The shares were price at an average price of 1.89 per share, with a total market value of 15,901. Following this completion of acquisition, the Chief Financial Officer, Bondurant William now holds 19,676 shares of the company’s stock, valued at 37,274. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.50%.
1 out of 4 analysts covering the stock have rated it a Buy, while 3 have maintained a Hold recommendation on Castlight Health Inc.. 0 analysts has assigned a Sell rating on the CSLT stock. The 12-month mean consensus price target for the company’s shares has been set at $2.00.